A novel standard to evaluate the impact of therapeutic agents on patient safety – The BURDEN OF THERAPY™©∗

Purpose: Currently, treatment-emergent adverse events (TEAEs) during a clinical study are summarized over the entire study period. Objective: Develop and validate a novel methodology, BURDEN OF THERAPY©∗ (BOTh©∗), to quantify presence and severity of TEAEs on each day of study. Methods: BOTh utilize...

Full description

Bibliographic Details
Main Authors: Ayad K. Abdulahad, Robert J. Snijder, Moeen K. Panni, Faysal K. Riaz, Andreas J. Karas
Format: Article
Language:English
Published: Elsevier 2016-12-01
Series:Contemporary Clinical Trials Communications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865416300400